Logo
REGENXBIO Inc.
biotechnology
Phone
(240) 552-8181
Employees
250
Headquarters
9600 Blackwell Road, Rockville, Maryland, United States, 20850
Headquarters
9600 Blackwell Road, Rockville, Maryland, United States, 20850
biotechnology, biopharmaceuticals, and gene therapy, biopharma, therapeutics, genetics
About REGENXBIO Inc.

REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprie...
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees. ----- REGENX Biosciences, LLC, a biopharmaceutical company, develops therapeutics and research tools based on adeno-associated viral (AAV) vectors. The company offers NAV, a gene delivery technology that includes recombinant adeno-associated viral vectors. Its technology is used for the treatment of metabolic disorders, muscle diseases, hematologic disorders, ocular diseases, and neurodegenerative disorders; and clinical trails in therapeutic areas, such as inherited diseases, CNS disorders, heart failure, and vaccines. The company also offers reagent services for various applications, including molecular therapies, understanding biological activity and target validation, creating disease models and screening in vivo, and genome-wide association studies. In addition, it offers custom products and services, including AAV plasmids, AAV Vector reporter systems, and custom AAV vectors to the researchers. The company is based in Washington, District Of Columbia. ----- REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees.
Compay BGContact Information
Join Apollo to reach decision makers at REGENXBIO Inc.
Contacts at REGENXBIO Inc.

Business Analyst
Director, Corporate Development
Associate Director, Corporate Development
Director Clinical Operations
Human Resources Specialist
Upstream Process Development Intern
Associate Scientist
Senior Clinical Development Lead
Senior Director, Intellectual Property
Senior Director, Clinical Research and Development, Ophthalmology Gene Therapy
Notable Alumni

Procurement & Supplier Development Manager -

Peer Career Counselor Co-Team Lead - Bryn Mawr College

President and Co-Founder - Agathos Biologics

Career Sabbatical - Self Employed

Vice President, Business Development - Almatica Pharma, Inc.

Director-Head Global Medical Affairs - Dr. Reddy's Laboratories

Project Manager I - Syneos Health

Associate Scientific Liaison - US Pharmacopeia

Project Coordinator and Client Services Representative, Enterprise and Mid-Atlantic - Kastle Systems

Browse Apollo's Directories

Company Search

Company Directory Search

People Search

People Directory Search

Find Verified Emails in Seconds

Use Apollo to easily get in touch with anyone in the world